Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Large Insider Purchases

Institutional-Scale SEC Form 4 Buy Signals

The Signal of $1M+ Conviction

When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.

Filing Date Trade Date Ticker Company Name Reporting Person Relationship Industry Type Price Qty Total, $ Owned After Change, %
2020-07-28 19:54 2020-07-28 ANNX Annexon, Inc. Flynn James E 10% owner, Other Pharmaceutical Preparations BUY $17.00 700,000 $11,900,000 808,914 +642.7%
2020-07-27 16:37 2020-07-23 LCRDX Lord Abbett Credit Opportunities Fund Christina & Robert Dow Foundation 10% owner Other BUY $9.05 1,215,470 $11,000,000 6,763,925 +21.9%
2020-07-27 23:11 2020-07-23 T AT&T INC. LUCZO STEPHEN J Director Telephone Communications (No Radiotelephone) BUY $29.69 100,000 $2,969,220 300,000 +50.0%
2020-07-28 03:02 2020-07-23 BAC BANK OF AMERICA CORP /DE/ BERKSHIRE HATHAWAY INC 10% owner National Commercial Banks BUY $24.22 16,424,366 $397,865,484 998,086,989 +1.7%
2020-07-28 00:03 2020-07-23 VSAT VIASAT INC BAUPOST GROUP LLC/MA 10% owner Communications Services, NEC BUY $39.11 2,556,891 $100,000,007 16,288,959 +18.6%
2020-07-25 01:50 2020-07-22 OSG N/A Saltchuk Resources, Inc. 10% owner Other BUY $2.48 2,187,058 $5,429,153 14,115,798 +18.3%
2020-07-24 23:03 2020-07-22 CASI N/A He Wei-Wu Director, Officer, 10% owner - Chairman and CEO Other BUY $1.90 4,152,426 $7,889,609 7,532,347 +122.9%
2020-07-23 23:32 2020-07-21 ONCT N/A Shanghai Pharmaceutical (USA) Inc. 10% owner Other BUY $2.38 1,049,317 $2,499,998 3,544,431 +42.1%
2020-07-22 23:30 2020-07-21 PAND N/A RA CAPITAL MANAGEMENT, L.P. 10% owner Other BUY $18.00 361,111 $6,499,998 1,770,023 +25.6%
2020-07-22 23:18 2020-07-21 ALXO Alx Oncology Holdings Inc. LSV Associates, LLC 10% owner Pharmaceutical Preparations BUY $19.00 400,000 $7,600,000 22,000 +100.0%
2020-07-22 23:18 2020-07-21 PAND N/A GLAXOSMITHKLINE PLC Director, 10% owner Other BUY $18.00 361,111 $6,499,998 2,248,304 +19.1%
2020-07-23 03:20 2020-07-20 BAC BANK OF AMERICA CORP /DE/ BERKSHIRE HATHAWAY INC 10% owner National Commercial Banks BUY $23.99 33,902,623 $813,327,316 981,662,623 +3.6%
2020-07-22 03:17 2008-03-11 EMR EMERSON ELECTRIC CO APERTURE TECHNOLOGIES INC Director Electronic & Other Electrical Equipment (No Computer Equip) BUY $50.00 1,000,000 $50,000,000 1,000,000 +100.0%
2020-07-22 03:04 2020-07-21 ALXO Alx Oncology Holdings Inc. Graham G. Walmsley Director Pharmaceutical Preparations BUY $19.00 975,000 $18,525,000 975,000 +100.0%
2020-07-22 02:39 2020-07-21 PAND N/A Becker Daniel J. Director, 10% owner Other BUY $18.00 723,222 $13,017,996 1,000 +100.0%
2020-07-22 03:25 2020-07-21 ALXO Alx Oncology Holdings Inc. Vivo Capital IX, LLC 10% owner Pharmaceutical Preparations BUY $19.00 975,000 $18,525,000 185,526 +100.0%
2020-07-21 13:03 2019-04-30 KXIN Kaixin Holdings Shareholder Value Fund 10% owner Retail-Auto Dealers & Gasoline Stations BUY $1.18 9,333,200 $10,989,843 9,413,200 +11,666.5%
2020-07-22 04:31 2020-07-21 ALXO Alx Oncology Holdings Inc. Lettmann Jason Director, 10% owner Pharmaceutical Preparations BUY $19.00 400,000 $7,600,000 22,000 +100.0%
2020-07-22 02:47 2020-07-21 PAND N/A Carroll Jill Director, 10% owner Other BUY $18.00 361,111 $6,499,998 2,248,304 +19.1%
2020-07-22 02:44 2020-07-21 PAND N/A Fuglesang Christopher Director, 10% owner Other BUY $18.00 722,222 $12,999,996 2,600,773 +38.4%
2020-07-22 04:29 2020-07-21 ALXO Alx Oncology Holdings Inc. Adelman Robert J 10% owner, Other Pharmaceutical Preparations BUY $19.00 853,000 $16,207,000 99,406 +100.0%
2020-07-22 03:01 2020-07-21 ALXO Alx Oncology Holdings Inc. GOODMAN COREY S Director, 10% owner, Other Pharmaceutical Preparations BUY $19.00 850,000 $16,150,000 850,000 +100.0%
2020-07-22 01:40 2020-07-17 APEN N/A McGaughy R Kent Jr Director, 10% owner Other BUY $1.25 1,780,000 $2,225,000 1,707,208 +100.0%
2020-07-22 01:39 2020-07-17 APEN N/A CPMG Inc 10% owner Other BUY $1.25 1,780,000 $2,225,000 1,707,208 +100.0%
2020-07-22 02:49 2020-07-21 PAND N/A Boxer Capital, LLC 10% owner Other BUY $18.00 722,222 $12,999,996 2,107,513 +52.1%
2020-07-21 00:35 2020-07-16 GES GUESS INC ALBERINI CARLOS Director, Officer - CEO and Director Women's, Misses': Children's & Infants' Undergarments BUY $10.17 100,000 $1,017,000 238,943 +72.0%
2020-07-17 23:16 2020-07-15 PSTL Postal Realty Trust, Inc. Spodek Andrew Director, Officer, 10% owner - CEO and Director Real Estate Investment Trusts BUY $13.03 78,195 $1,018,928 108,695 +256.4%
2020-07-18 01:32 2020-07-16 EQS EQUUS TOTAL RETURN, INC. Hardy John A. Director, Officer, 10% owner - CEO Other BUY $1.17 3,228,024 $3,776,788 3,728,024 +645.6%
2020-07-18 04:58 2020-07-15 DMS N/A Lea Lyndon Director Other BUY $9.36 2,000,000 $18,720,000 2,000,000 +100.0%
2020-07-16 18:29 2020-07-14 LCRDX Lord Abbett Credit Opportunities Fund Christina & Robert Dow Foundation 10% owner Other BUY $8.94 2,460,850 $22,000,000 5,548,456 +79.7%
2020-07-17 00:00 2020-07-14 NKTK Nkarta, Inc. Makhzoumi Mohamad 10% owner Pharmaceutical Preparations BUY $18.00 666,666 $11,999,988 2,902,115 +29.8%
2020-07-17 00:00 2020-07-14 NKTK Nkarta, Inc. New Enterprise Associates 15, L.P. 10% owner Pharmaceutical Preparations BUY $18.00 666,666 $11,999,988 2,902,115 +29.8%
2020-07-17 00:00 2020-07-14 NKTK Nkarta, Inc. Florence Anthony A. Jr. 10% owner Pharmaceutical Preparations BUY $18.00 666,666 $11,999,988 2,902,115 +29.8%
2020-07-17 00:00 2020-07-14 NKTK Nkarta, Inc. Sonsini Peter W. 10% owner Pharmaceutical Preparations BUY $18.00 666,666 $11,999,988 2,902,115 +29.8%
2020-07-16 23:41 2020-07-14 NKTX Nkarta, Inc. Novo Holdings A/S 10% owner Pharmaceutical Preparations BUY $18.00 555,555 $9,999,990 2,793,865 +24.8%
2020-07-16 23:30 2020-07-14 NKTX Nkarta, Inc. RA CAPITAL MANAGEMENT, L.P. 10% owner Pharmaceutical Preparations BUY $18.00 3,333,333 $59,999,994 5,605,129 +146.7%
2020-07-17 00:00 2020-07-14 NKTK Nkarta, Inc. BASKETT FOREST 10% owner Pharmaceutical Preparations BUY $18.00 666,666 $11,999,988 2,902,115 +29.8%
2020-07-17 00:00 2020-07-14 NKTK Nkarta, Inc. SANDELL SCOTT D 10% owner Pharmaceutical Preparations BUY $18.00 666,666 $11,999,988 2,902,115 +29.8%
2020-07-17 00:00 2020-07-14 NKTK Nkarta, Inc. MAKOWER JOSHUA 10% owner Pharmaceutical Preparations BUY $18.00 666,666 $11,999,988 2,902,115 +29.8%
2020-07-17 03:13 2020-07-14 NKTX Nkarta, Inc. GLAXOSMITHKLINE PLC Director, 10% owner Pharmaceutical Preparations BUY $18.00 833,333 $14,999,994 3,150,732 +36.0%
2020-07-15 23:56 2020-04-17 IMBI N/A Lalo Eyal Director Other BUY $2.04 693,370 $1,416,208 1,093,370 +173.3%
2020-07-15 23:57 2020-04-17 IMBI N/A Friedman Michael Director Other BUY $2.06 653,348 $1,347,988 912,949 +251.7%
2020-07-16 00:00 2020-07-14 PSTX N/A Hirsch David Director Other BUY $16.00 250,000 $4,000,000 2,714,245 +10.1%
2020-07-16 00:11 2020-07-13 TSE Trinseo PLC M&G INVESTMENT MANAGEMENT LTD 10% owner Plastic Materials, Synth Resins & Nonvulcan Elastomers BUY $21.81 310,510 $6,772,223 7,804,044 +4.1%
2020-07-16 01:16 2020-07-13 IDRA N/A Pillar Invest Corp 10% owner Other BUY $1.72 749,993 $1,289,988 5,427,697 +16.0%
2020-07-15 03:08 2020-07-10 ETNB N/A Grunberg Gregory Director, 10% owner Other BUY $27.50 109,090 $2,999,975 2,600,877 +4.4%
2020-07-14 23:46 2020-07-10 AKRO Akero Therapeutics, Inc. Apple Tree Partners IV, L.P. 10% owner Pharmaceutical Preparations BUY $36.00 415,000 $14,940,000 5,830,203 +7.7%
2020-07-14 23:45 2020-07-10 AKRO Akero Therapeutics, Inc. Harrison Seth Loring Director, 10% owner Pharmaceutical Preparations BUY $36.00 415,000 $14,940,000 5,830,203 +7.7%
2020-07-15 03:11 2020-07-10 ETNB N/A Longitude Capital Partners III, LLC 10% owner Other BUY $27.50 109,090 $2,999,975 2,600,877 +4.4%
2020-07-15 01:54 2020-07-10 WCC WESCO INTERNATIONAL INC Green Equity Investors VII, L.P. 10% owner Wholesale-Electrical Apparatus & Equipment, Wiring Supplies BUY $35.78 962,805 $34,447,045 3,087,281 +45.3%
SHOW ENTRIES

Institutional Conviction in Form 4

Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.

Filtering the Market Noise

Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.